Key Highlights
- IBEX Limited reported fourth quarter Revenue of 164.3 million dollars, beating the 160 million dollar estimate by about 2.65 percent.
- Adjusted Earnings Per Share of 0.85 dollars topped the 0.85 dollar estimate, in line with expectations by a slight 0.59 percent margin.
- Full year revenue reached a record 644.1 million dollars, up 15.4 percent, marking the sixth consecutive quarter of double digit growth.
- The health tech vertical grew 38 percent for the year to 114 million dollars, surpassing the company's 100 million dollar target.
A Sixth Straight Quarter of Double Digit Growth
IBEX Limited (NASDAQ:IBEX), a global provider of customer experience and Business process outsourcing services, reported fourth quarter revenue of 164.3 million dollars, up 12 percent year over year and ahead of the 160 million dollar analyst estimate. Full year revenue reached a record 644.1 million dollars, an increase of 15.4 percent, extending the company's streak to six consecutive quarters of double digit growth.
Growth was led by the company's health tech vertical, which expanded 42 percent in the fourth quarter and 38 percent for the full year to 114 million dollars, comfortably surpassing a previously stated target of building the segment into a 100 million dollar business. Technology, travel and transportation, and retail and E-commerce verticals also posted solid growth during the period.
AI Agent Partnership Emerges as a New Growth Vector
IBEX's strategic partnership with Sierra AI, formalized in January and announced publicly in May, has begun generating tangible results across multiple client engagements. The company cited case studies with Philippine Airlines and BJ's Wholesale where AI agent deployments achieved resolution rates between 20 and 40 percent alongside customer satisfaction scores comparable to or exceeding traditional human agents.
Management emphasized that these AI deployments have not cannibalized existing human agent revenue, instead functioning as a complementary growth channel that has helped win new trophy client relationships. Adjusted EBITDA for the quarter came in at 20.2 million dollars, or 12.3 percent of revenue, a slight decline from the prior year period reflecting costs associated with new client onboarding and a shift of some Volume from nearshore to offshore delivery centers.
Balancing AI Driven Growth Against Margin Pressure
Continued expansion of AI agent deployments across the company's five existing verticals could support both new client wins and expanded volume within IBEX's existing client base, potentially creating a durable second growth engine alongside its traditional human agent business. The company's guidance for fiscal 2027 calls for revenue growth of 9 to 11 percent and adjusted EBITDA growth of 9 to 14 percent, suggesting management expects margin expansion to resume after the fourth quarter dip.
At the same time, near term margin pressure from new client onboarding costs and delivery center transitions could persist if growth continues at its current pace, and the broader business process outsourcing industry faces ongoing questions about how artificial intelligence will reshape Demand for traditional human agent services over time.
The Road Ahead
IBEX Limited closed fiscal 2026 with record revenue and a sixth consecutive quarter of double digit growth, supported by strength in health tech and early traction from its AI agent partnership with Sierra AI. Whether the company can sustain this growth trajectory into fiscal 2027 may depend on how effectively it scales AI deployments across its client base while managing the margin pressures associated with rapid new client onboarding. Management's guidance suggests confidence that margin expansion will resume even as growth continues.
_11_19_2026_19_19_13_574021.jpg)





Please wait processing your request...